Skip to main navigation Skip to search Skip to main content

Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events

  • Vera E. R. Asscher*
  • , Quirine van der Vliet
  • , Karen van der Aalst
  • , Anniek van der Aalst
  • , Eelco C. Brand
  • , Andrea E. van der Meulen-de Jong
  • , Bas Oldenburg
  • , Marieke J. Pierik
  • , Bas van Tuyl
  • , Nofel Mahmmod
  • , P. W. Jeroen Maljaars
  • , Herma H. Fidder
  • , Dutch ICC
  • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events'. Together they form a unique fingerprint.
Sort by

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science